Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn)

NCT02182843 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT02182843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02182843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn)
Lead sponsor
Zimmer Biomet
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2014
Completion date
January 31, 2018
Enrollment
81 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cervical disc degenerative disorder